From: How frail is frail? A systematic scoping review and synthesis of high impact studies
 | Author, Year, Country | FCWI | Study Design | N | Mean Age in years (SD) | % Female | Mean FI (SD) | FI Categories: scores and labels | Rationale & Comments |
---|---|---|---|---|---|---|---|---|---|
Community | Clegg et al., 2016 UK [7] | 19.42 | Cohort | 931,541 | 75.0 (7.2) | 55.0 | Development and internal validation cohort = 0.14 (0.09) External validation cohort = 0.15 (0.10) | <  0.12 (fit) >  0.12–0.24 (mild frailty) >  0.24–0.36 (moderate frailty) >  0.36 (severe frailty) | Study authors derived FI quartiles using 99th centile as upper limit. |
Wallace et al., 2019 USA [8] | 17.94 | Cross-sectional | 456 | 89.7 (6.1) | 69.0 | 0.42 (0.18) | ≥ 0.41 (median) (high frailty) 0.24–0.41 (low frailty) 0.42 (intermediate frailty) 0.43–0.60 (high frailty) | Study authors derived FI categories utilising the median and then using the mean + −  1 SD. | |
Rockwood et al., 2011 Canada [9] | 17.78 | Cohort | 14,127 | 44.3 (18.3) | 54.2 | 0.07 (0.08) | ≤ 0.03 (relatively fit) 0.03 < FI ≤ 0.10 (less fit) 0.10 < FI ≤ 0.21 (least fit) >  0.21 (frail) ≥ 0.45 (most frail) | Referenced Rockwood et al.’s study [4], which demonstrated construct and predictive validity of Clinical Frailty Scale (CFS) categories in study of community-dwellers. CFS categories ≥4 (‘apparently vulnerable’- ‘severely frail’) corresponded with a mean FI > 0.21. | |
Theou et al., 2013 11 European countries [10] | 11.00 | Cohort | 27,527 | 65.3 (10.5) | 54.8 | Not reported | ≥ 0.25 (frail) | Referenced Rockwood et al.’s study [3], which demonstrated the construct and predictive validity of FI > 0.25 in community-dwellers. | |
Blodgett et al., 2015 Canada [11] | 8.52 | Cross-sectional | 4096 | 63.4 (10.3) | 53.3 | 0.20 men 0.17 women | ≤ 0.10 (non-frail) 0.10 < FI ≤ 0.21 (vulnerable) 0.21 < FI ≤ 0.45 (frail) >  0.45 (most frail) | Referenced Hoover et al.’s study [12], which demonstrated the predictive validity of FI > 0.21 cut-off as well as four frailty categories (as listed here). | |
Thompson et al., 2018 Australia [13] | 7.23 | Cohort | 909 | 74.4 (6.2) | 55.0 | 0.23 (0.15) | ≤ 0.21 (non-frail and prefrail) >  0.21 (frail and most frail) | Referenced Hoover et al. [12] | |
Ntanasi et al., 2018 Greece [14] | 6.76 | Cross-sectional | 1740 | 73.4 (5.4) | 59.0 | Not reported | > 0.25 (frail) | Referenced Rockwood et al. [3] | |
Song et al., 2010 Canada [15] | 6.51 | Cohort | 2740 | 74.0 (6.6) | 60.8 | Not reported | ≤ 0.08 (non-frail) 0.09–0.24 (prefrail) ≥ 0.25 (frail) | Referenced Rockwood et al. [3] | |
Ravindrarajah et la., 2017 UK [16] | 6.00 | Cohort | 144,403 | 85.1 (4.9) – 88.0 (5.4) | 50–68 | Not reported | <  0.12 (fit) >  0.12–0.24 (mild frailty) >  0.24–0 36 (moderate frailty) >  0.36 (severe frailty) | Referenced Clegg et al.’s study [7], which demonstrated the predictive validity of these eFI categories in UK community-dwellers. | |
Lansbury et al., 2017 UK [17] | 5.22 | Cross-sectional | 589 | 82.7 | 58.1 | 0.23 (0.12) | <  0.12 (fit) >  0.12–0.24 (mild frailty) >  0.24–0.36 (moderate frailty) >  0.36 (severe frailty) | Referenced Clegg et al. [7] | |
Acute Care | Joseph et al., 2014 USA [18] | 15.46 | Cohort | 250 | 77.9 (8.1) | 30.8 | 0.21 (0.10) | <  0.25 (non-frail) ≥ 0.25 (frail) | Referenced Searle et al.’s study [2], which did not report FI categories. |
Chong et al., 2018 Singapore [19] | 5.49 | Cohort | 210 | 89.4 (4.6) | 69.5 | Not reported | ≥ 0.25 (frail) | Nil | |
Joseph et al., 2016 USA [20] | 5.03 | Cohort | 220 | 75.5 (7.7) | 44.0 | 0.28 (0.13) | <  0.25 (non-frail) ≥ 0.25 (frail) | Referenced study by co-authors [18] and a conference abstract. | |
Poudel et al., 2016 Australia [21] | 4.93 | Cohort | 1418 | 81 (6.8) | 55.0 | 0.32 (0.15) | <  0.25 (low) 0.26–0.39 (medium) ≥ 0.4 (high) | Referenced Rockwood et al. [3, 4] Also referenced Singh et al.’s study [22], which utilised similar categories and referenced Rockwood et al. [3, 4] | |
Andrew et al., 2017 Canada [23] | 4.87 | Case control | 884 | 78.8 (7.9) – 80.6 (9.0) | 55.0–56.9 | Cases = 0.2 (0.11) Controls = 0.22 (0.13) | <  0.10 (non-frail) >  0.10–0.21 (prefrail) >  0.21–0.45 (frail) | Referenced Hoover et al. [12] | |
Dent et al., 2014 Australia [24] | 4.22 | Cohort | 172 | Not reported | 72.0 | Not reported | <  0.2 (robust) 0.2–0.45 (prefrail) >  0.45 (frail) | Referenced Rockwood et al. [4] | |
Mueller et al., 2016 USA [25] | 4.16 | Cohort | 102 | 61.9 (15.8) | 39.2 | 0.23 (0.12) | <  0.25 (non-frail) ≥ 0.25 (frail) | Referenced Joseph et al. [18] | |
Zeng et al., 2015 China [26] | 2.92 | Cohort | 155 | 82.7 (7.1) | 12.9 | Not reported | <  0.22 (least frail) >  0.46 (least fit) | Authors determined FI scores below which all participants survived and above which all participants died. | |
Hao et al., 2019 China [27] | 2.86 | Cohort | 271 | 81.1 (6.6) | 20.3 | 0.26 (0.16) | >  0.25 (frail) | Referenced Rockwood et al. [3] Also referenced several other studies that utilised the same categories and referenced Rockwood et al. [3, 4]. | |
Arjunan et al., 2019 Australia [28] | 2.83 | Cohort | 258 | 79.0 (8.0) | 54.0 | 0.42 (0.13) | ≤ 0.40 (less frail) >  0.40 (more frail) | Authors determined the FI cut point for optimal sensitivity and specificity for four adverse outcomes. | |
Residential Aged Care | Theou et al., 2018 Spain [29] | 4.00 | RCT | 50 | 75.3 (7.3) | 70.0 | 0.23 (0.1) | <  0.20 (non-frail) 0.20–0.30 (vulnerable/mildly frail) >  0.30 (moderately/severely frail) | Study authors categorised the FI in 0.1 groups then combined groups due to the small number of participants. They referenced two studies [30, 31], which both categorised the FI into 0.1 increments to facilitate regression analyses. |
Shaw et al., 2019 Canada [32] | 3.84 | Cohort | 116 | 84.2 (0.9) | 56.0 | 0.36 (0.01) | <  0.27 (non-frail) ≥ 0.27 (frail) | Study authors demonstrated a bimodal distribution of the continuous FI with ‘crossing points’ at an FI = 0.27. | |
Theou et al., 2018 Australia [33] | 3.26 | Cohort | 383 | Median 88.0 IQR 4.0 | 77.6 | 0.33 (0.24–0.46) | ≤ 0.10 (non-frail) 0.10–0.21 (vulnerable) 0.21–0.44 (mild/moderate frailty) ≥ 0.45 (most frail) | Referenced study by co-authors [34], which utilised the same categories and referenced Hoover et al. [12] | |
Maclagan et al., 2017 Canada [35] | 2.33 | Cohort | 41,351 | Not reported | 64.7 | Not reported | <  0.20 (robust / non-frail) 0.20–0.30 (pre-frail) >  0.30 (frail) | Referenced study by co-authors [36], which utilised the same FI categories, referencing Searle et al. [2], co-authors Hogan et al. [37] (see below) and Kulminski et al. [38] Kulminski et al.’s study [38] demonstrated the predictive validity of similar FI categories in community-dwellers. | |
Hogan et al., 2012 Canada [37] | 2.03 | Cohort | 1066 | 84.9 (7.3) | 76.7 | Not reported | <  0.20 (robust / non-frail) ≥ 0.20 ≤ 0.30 (prefrail) >  0.30 (frail) | ||
Buckinx et al., 2017 Belgium [39] | 1.24 | Cohort | 662 | 83.2 (9.0) | 72.5 | Not reported | <  0.25 (robust) ≥ 0.25 (frail) | Referenced a review article [40] and Mitnitski et al.’s study [41], which based ‘FI-Biomarker’ categories on maximum separation of mortality curves in community-dwellers. | |
Ambagtsheer et al., 2020 Australia [42] | 1.23 | Cross-sectional | 592 | Median 88.0 IQR 9.0 | 66.6 | 0.20 (0.08) | ≤ 0.10 (non-frail) > 0.10 ≤ 0.21 (pre-frail) >  0.21 (frail) | Referenced Hoover et al. [12] | |
Ambagtsheer et al., 2020 Australia [43] | 1.03 | Cross-sectional | 592 | Median 88.0 IQR 9.0 | 66.6 | Not reported | ≤ 0.21 (non-frail) >  0.21 (frail) | Referenced Hoover et al. [12] | |
Ge et al., 2019 China [44] | 0.72 | Cross-sectional | 302 | 82.7 (8.5) | 71.2 | 0.27 (0.11) | <  0.21 (non-frail) 0.22–0.44 (frail) ≥ 0.45 (frailest) | Referenced Hoover et al. [12] | |
Stock et al., 2017 Canada [45] | 0.54 | Cohort | 1066 | 84.4 (7.3) | 76.7 | Not reported | <  0.20 (non-frail) 0.20–0.30 (prefrail) >  0.30 (frail) | Referenced study by co-authors [37] (see above). |